Hospital
Amisub (SFH), INC.
Amisub (SFH), INC. was paid $20.31M by Medicaid between Jan 2018 and Dec 2024, across 137 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoAMISUB (SFH), INC.
MEMPHIS, TN 38119
MEMPHIS, TN 38119
33aNPI1952326977assigned 07/12/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$20.31M
24GClaims580,520
24DCodes billed137
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#13 of 71
Median peer was paid$6.96M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,968 | $3.19M | |
| 2019 | 103,953 | $3.48M | |
| 2020 | 76,988 | $2.67M | |
| 2021 | 75,850 | $2.69M | |
| 2022 | 86,774 | $2.96M | |
| 2023 | 87,247 | $3.10M | |
| 2024incomplete | 59,740 | $2.22M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 48,504 | 43,995 | $5.70M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 22% | 28,913 | 25,358 | $4.48M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 45,743 | 41,990 | $4.29M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 5.6% | 20,121 | 18,100 | $1.13M |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 2.3% | 3,247 | 3,092 | $469K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 5,295 | 4,950 | $349K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 13,704 | 11,927 | $345K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.5% | 8,677 | 7,884 | $313K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.3% | 5,298 | 4,629 | $259K |
| 84484 | 1.2% | 19,151 | 15,105 | $235K | |
| 71045 | Radiologic examination, chest; single view | 1.1% | 20,714 | 18,170 | $232K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.1% | 3,663 | 3,425 | $229K |
125 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.1% | 49,336 | $221K |
| 76801 | <1% | 2,905 | $181K | |
| 57425 | <1% | 92 | $156K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 8,784 | $147K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,386 | $124K |
| 80047 | <1% | 16,536 | $123K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 26,543 | $116K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 7,759 | $115K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 845 | $112K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,277 | $102K |
| 80053 | Comprehensive metabolic panel | <1% | 26,237 | $89K |
| 81025 | <1% | 33,564 | $87K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 400 | $61K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,631 | $57K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,705 | $54K |
| 87400 | <1% | 6,928 | $52K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 6,044 | $43K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12,835 | $39K |
| G0378 | Hospital observation service, per hour | <1% | 6,068 | $38K |
| 83690 | <1% | 6,284 | $33K | |
| 81001 | <1% | 36,073 | $33K | |
| 58571 | <1% | 55 | $32K | |
| 58661 | <1% | 19 | $31K | |
| 58662 | <1% | 41 | $30K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 422 | $27K |
| 85027 | <1% | 7,942 | $26K | |
| 83880 | <1% | 2,715 | $24K | |
| 64488 | <1% | 426 | $19K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 393 | $18K |
| 84702 | <1% | 633 | $14K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 97 | $7K |
| 80061 | Lipid panel | <1% | 1,062 | $5K |
| 82962 | <1% | 4,212 | $5K | |
| 87081 | <1% | 711 | $4K | |
| 85379 | <1% | 167 | $4K | |
| 80076 | <1% | 647 | $3K | |
| 83970 | <1% | 293 | $3K | |
| 85610 | <1% | 2,679 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 405 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 994 | $2K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 578 | $2K |
| 96376 | <1% | 426 | $2K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 15 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 241 | $2K |
| 82607 | <1% | 376 | $1K | |
| 86900 | <1% | 1,051 | $1K | |
| 86901 | <1% | 1,052 | $1K | |
| 95816 | <1% | 32 | $1K | |
| 82746 | <1% | 339 | $1K | |
| 74220 | <1% | 13 | $1K | |
| 87088 | <1% | 128 | $1K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 49 | $1K |
| 72040 | <1% | 96 | $1K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 13 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 15 | $1K |
| 73564 | <1% | 45 | $948.87 | |
| G0257 | Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility | <1% | 49 | $941.26 |
| 85730 | <1% | 317 | $919.21 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 6,246 | $800.22 |
| 90715 | <1% | 12 | $758.50 | |
| 82565 | <1% | 270 | $721.18 | |
| 83735 | <1% | 403 | $657.41 | |
| 72110 | <1% | 30 | $629.02 | |
| 84703 | <1% | 849 | $619.17 | |
| 83605 | <1% | 93 | $601.82 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 16,396 | $591.24 |
| 84439 | <1% | 281 | $556.03 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 730 | $474.89 |
| 94664 | <1% | 31 | $446.38 | |
| 84550 | <1% | 352 | $445.68 | |
| 82550 | <1% | 269 | $415.94 | |
| 86140 | <1% | 293 | $389.01 | |
| 86886 | <1% | 844 | $374.79 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 196 | $363.29 |
| 73610 | <1% | 16 | $333.62 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,286 | $319.16 |
| 87810 | <1% | 14 | $299.33 | |
| 87210 | <1% | 42 | $270.28 | |
| 84145 | <1% | 90 | $245.49 | |
| 73130 | <1% | 14 | $238.30 | |
| 73030 | <1% | 16 | $228.06 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 161 | $199.70 |
| 88307 | <1% | 181 | $193.40 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 797 | $183.76 |
| 82728 | <1% | 15 | $166.44 | |
| 87040 | <1% | 56 | $157.68 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 994 | $142.08 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 135 | $135.80 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 693 | $112.55 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 512 | $107.81 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $95.11 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 14 | $95.11 |
| 83550 | <1% | 16 | $84.45 | |
| 74018 | <1% | 15 | $75.49 | |
| 84100 | <1% | 80 | $59.82 | |
| 83540 | <1% | 16 | $59.28 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,044 | $50.34 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 2,393 | $48.74 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,347 | $42.59 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 148 | $36.92 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 517 | $33.88 |
| 86705 | <1% | 18 | $31.91 | |
| 86706 | <1% | 18 | $29.10 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 13,373 | $28.14 |
| 94760 | <1% | 24 | $24.34 | |
| 87340 | <1% | 18 | $23.72 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 738 | $8.83 |
| 86592 | <1% | 30 | $8.79 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 0% | 41 | $0.00 |
| 88302 | 0% | 15 | $0.00 | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | 0% | 169 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 33 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 38 | $0.00 |
| S0028 | Injection, famotidine, 20 mg | 0% | 14 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 2,814 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 1,288 | $0.00 |
| A9270 | Non-covered item or service | 0% | 11,784 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 724 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 1,204 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 848 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 62 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 161 | $0.00 |
| J3490 | Unclassified drugs | 0% | 112 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 46 | $0.00 |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialNELSON, RYAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Saint Francis Hospital - Bartlett, INC. | Bartlett, TN | $9.85M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.